ION
Market cap | $30.40 Million |
---|---|
Enterprise Value | $34.56 Million |
Dividend Yield | $0.521761 (1.68800064703979%) |
Earnings per Share | $- |
Beta | 1.58 |
Outstanding Shares | - |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | - |
---|---|
PEG | - |
Price to Sales | - |
Price to Book Ratio | - |
Enterprise Value to Revenue | 1.91 |
Enterprise Value to EBIT | -3.9 |
Enterprise Value to Net Income | -5 |
Total Debt to Enterprise | 0.43 |
Debt to Equity | 0.69 |
No data
No data
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets bas...